Cite

HARVARD Citation

    Italiano, A. et al. (2020). Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. Lancet oncology. 21 (3), pp. 446-455. [Online]. 
  
Back to record